Smith & Nephew plc

NYSE:SNN

Medical - Devices

Healthcare
$30.32 -1.39%

-$0.43 today

Market cap
$12.72B
Beta
0.67
P/E (TTM)
20.1
EPS (TTM)
$0.74
Dividend yield
2.59%
52W Low $28.79High $38.79

Volume 1.22M

Average 1.10M

SNN Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Smith & Nephew plcNYSE: SNN

Net Income · Q4 FY2025 · quarter ended Dec 2025

Net income grows 67.7% year over year

Q4 FY2025 net income of $332M rose 67.7% year over year. Over 3 fiscal years it compounded at +41.0% a year.

Context

  • Net income amounted to 10.1% of revenue in FY2025, up 3.0 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 7 analysts of $931.84M (+49.1%) for the fiscal year ending Dec 2026, a slowdown from the +51.7% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
$332M— QoQ
Last fiscal yearDec 2025
$625M+51.7% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+67.7%——
1 year+51.7%+49.1%-2.6 pp
3-year CAGR+41.0%+21.4%-19.6 pp
5-year CAGR+16.1%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
625M USD
Year-over-year change
+51.7%
4-year CAGR
+4.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SNN compares with its peers on the latest reported figures

  • SNN's FY2025 net income of $625M is the 4th largest of the 11 companies compared; the peer median is $18.93M.
  • Its year-over-year change of +51.7% is the 3rd highest of 11, against a peer median of +26.1%.
  • Net income amounts to 10.1% of revenue for SNN, versus a peer median of 16.1%.
SNN Competitors Peer median
Net Income for SNN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$3.73B +27.8%+11.2%14.4%
ENOVEnovis CorporationLTM Apr 2026$1.12B +38.5%+365.2%49.1%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$808.5M -2.0%+34.3%9.5%
SNNSmith & Nephew plcFY2025$625M +51.7%+41.0%10.1%
GMEDGlobus Medical, Inc.LTM Jun 2026$535.43M +50.1%+41.4%17.0%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$495.8M +1612.2%—30.1%
OFIXOrthofix Medical Inc.LTM Mar 2026$178.05M +24.5%+67.1%21.6%
ATECAlphatec Holdings, Inc.LTM Mar 2026$125.36M -24.3%-1.8%15.9%
CNMDCONMED CorporationLTM Mar 2026$54.85M -53.8%—4.0%
KIDSOrthoPediatrics Corp.LTM Mar 2026$39.68M -2.5%—16.3%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$1.83M +115.2%—1.5%
Peer median (excluding SNN) $18.93M+26.1%+37.9%16.1%

Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income524M223M263M412M625M
Depreciation & Amortization563M548M527M555M573M
Deferred Income Tax00000
Stock-Based Compensation41M40M39M40M43M
Change in Working Capital(232M)(510M)(227M)(123M)33M
Accounts Receivables(81M)(103M)(49M)(81M)(175M)
Inventory(151M)(407M)(178M)(42M)208M
Accounts Payables00000
Other Working Capital00000
Other Non-Cash Items(19M)167M6M103M11M
Operating Cash Flow877M468M608M987M1.29B
Capital Expenditures(408M)(358M)(427M)(381M)(433M)
Acquisitions (Net)(285M)(113M)(21M)(186M)(9M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities2M(1M)0(2M)36M
Investing Cash Flow(691M)(472M)(448M)(569M)(406M)
Debt Repayment(59M)(43M)(52M)945M(140M)
Common Stock Issued00000
Common Stock Repurchased0(158M)00(502M)
Dividends Paid(329M)(327M)(327M)(327M)(330M)
Other Financing Activities(257M)(398M)179M(704M)17M
Financing Cash Flow(645M)(926M)(200M)(86M)(955M)
Effect of Forex Changes(7M)(11M)(4M)(15M)14.18M
Net Change in Cash(466M)(941M)(44M)317M(62M)
Free Cash Flow469M110M181M606M852M

Smith & Nephew plc

NYSE:SNN

Intrinsic Alpha fair value

Locked

Current Price

$30.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.